Clinical Trial

Quality of Life In Patients With Allergic Conjunctivitis In Treatment With Sublingual Allergen Immunotherapy In A Referral Ophthalmological Hospital

Study acronym: CVCA
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to evaluate both clinical changes and quality-of-life outcomes in patients with allergic conjunctivitis treated with allergen-specific immunotherapy, integrating objective clinical parameters and validated quality-of-life measures to obtain a comprehensive view of the therapeutic impact.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-27.
Trial Details
NCT Number NCT07149298
Lead Sponsor Instituto de Oftalmología Fundación Conde de Valenciana
Conditions Allergic Conjunctivitis of Both Eyes
Enrollment 100 participants
Start Date 2014-03-24
Primary Completion 2023-10-09 (estimated)
Study Completion 2026-03 (estimated)
Updated on ClinicalTrials.gov 2025-09-08